Mitochondrial (mt) DNA is highly susceptible to mutation.
Introduction
gene therapy using cytoplasts will overcome these diffiUnlimited replicative capacity: unlike somatic cell chromoculties. Here we present data on the in vitro gene therapy somes, due to lack of telomerase in mtDNA, which is circuof human mtDNA. 3, 4 which will be useful plasmy (Figure 1 ). During the mitosis of a heteroplasmic in the gene therapy of mtDNA. cell, both mutated and normal mtDNA are divided Because mtDNA has much higher information density unevenly into the daughter cells. Consequently, over (no exon) than nDNA, it is an excellent target for repeated cell divisions, the cell lines are separated into mutations giving rise to human diseases. Oxidants genertwo kinds of homoplasmic cells containing either normal ated by mitochondrial aerobic metabolism are the major source of the oxidative lesions that cause mutations of mtDNA. 5 The higher levels of oxidative damage and mutation of mtDNA are ascribed to three factors: (1) location of the mtDNA in mitochondria where reactive drome. 11 A marked decrease in the number of mtDNA is associated with a familial mitochondrial myopathy. 12 oxygen species are formed; (2) lack of protective histones in mtDNA; and (3) the limited repertoire of DNA repair While maternal transmission of mutated mtDNA has been established, maternal inheritance through multiple mechanisms in mitochondria. 6 They only have uracil glycosylase and can therefore correct only cytosine deamingenerations has not. However, this could be explained by replicative segregation and threshold expression. For ation. Their repair system for pyrimidine dimers is lacking. Moreover, the mtDNA polymerase has no example, clinically overt seizures of MELAS or MERRF only occur in individuals with the highest percentage of proofreading ability.
Mutations causing mtDNA diseases fall into four mutant mtDNAs. The same MELAS mutation in mtDNA may cause encephalomyopathy, 7,8 diabetes mellitus 13 or groups: (1) missense mutations; (2) protein synthesis mutations; (3) insertion-deletion mutations; and (4) copy even hypopituitarism. 14 This is attributed to the stochastic segregation of the mutant mtDNA in different tissues number mutations. (Figure 1, left) . Mitochondria in a cytodisease (MERRF), 9 and maternally inherited cardiomyopathy (CM). 10 The major mutations in MELAS, MERRF plast do not proliferate, because all the enzymes essential for the replication, transcription and translation of and CM are localized at np 3243 (A to G; tRNA Leu(UUR) ), 7, 8 np 8344 (A to G; tRNA Lys ), 9 and np 4269 (A to G; mtDNA are supplied from the nucleus. Thus, the cytoplasts containing normal mtDNA are prepared from the tRNA Ile ), 10 respectively. Deletions in mtDNA have been found to cause the majority of cases of chronic progresshomoplasmic cells which are selected by proliferating the patient's heteroplasmic cells in the galactose-rich, gluive external ophthalmoplegia and Kearn-Sayre syn-cose-deficient culture medium (Figure 1, bottom right) . 18 Human cells with mutant mtDNA lacking or with lowered oxidative phosphorylation are dependent on glycolysis, and cannot survive in the galactose-pyruvate medium DM170. 17, 19 So, as the first step, it is necessary to grow the isolated heteroplasmic cells in a glucosepyruvate medium. The addition of pyruvate (0.1 mg/ml) to glucose medium is essential to support these defective cells, because most NAD is reduced in the absence of electron transport. After the stochastic segregation, the normal homoplasmic cells are selected.
Cells without mtDNA are called o cells (Figure 1, left 19 By fusing homoplasmic or heteroplasmic cytoplasts with the o cells the properties of mutant DNA in the resulting cybrids can be analyzed (Figure 1 ). (Figure 1, left) . The fusion The introduction of normal mtDNA via cytoplasts into mixture was cultivated in selection medium DM170 17 the heteroplasmic cell is effective, as shown by the prosupplemented with 20 m 6-thioguanine and serum.
How to use the cytoplast for intercellular
duction of fusion proteins. The formation of fusion proUnfused o HeLa cells were glycolysis-dependent and teins of deleted mtRNA transcribed from deleted mtDNA thus did not survive in DM170. Unfused cytoplasts and in heteroplasmic cells indicated intermitochondrial comparental cells for the cybrid were also removed with 6-munication because the deletion resulted in the lack of thioguanine. several tRNAs. 19 The fusion mtRNAs were translated into Human skin fibroblast lines isolated from a CM patient fusion proteins by a sufficient supply of tRNAs from the with a tRNA Ile 4269 mutation (Figure 2 , P) have a differnormal mtDNA coexisting in the cells. 18 Thus, the ent restriction site with SspI from those isolated from the amount of normal mtDNA introduced to complement the control wild-type cell line (Figure 2, C) . On fusion with defective mtDNA was only about 20% of the total HeLa o cells, the cytoplasts from the mutant cells gave mtDNA in a cell. The morphology of all mitochondria in cybrid lines such as CM-1-9 with mostly normal mtDNA defective cells in which all mitochondria were swollen ( Figure 2 , CM 1-9) and CM-1-1-4 with mainly (Ͼ95%) was also normalized by the introduction of normal mutant DNA (Figure 2, CM 1-1-4) , due to the stochastic mtDNA.
17 segregation during the culture. 17,18 Electron micrographs stained for cytochrome oxidase (COX) activity showed that almost all individual mitochondria in CM 1-1 cells
Applications of cytoplasts for human gene
were COX-positive (Figure 3a) , while those in CM1-1-4 therapy cells were COX-negative (Figure 3b) .
Similarly, we could restore the COX activity of the The intravenous infusion of cytoplasts is the same as that of hepatocytes in ex vivo gene therapy directed to liver via HeLa o cells by introducing wild-type mtDNA either from the original HeLa cells, MELAS3243, and CM4269 the inferior mesenteric vein. 22 Our first target is diabetes mellitus caused by MELAS mutation in the pancreas, 13 ( Figure 4 , HeEB, ML3-6 and CM1-9, respectively). However, when mutant mtDNAs from the patients were which is the most frequent genetic disease in Japan. For cybrid formation, the fusion protein of Sendai virus etc introduced into the HeLa o cells, COX activity was not restored (Figure 4, ML3-7-2 and CM1-1-4) . Other activican be used in place of polyethylene glycol. Cytoplasts with normal mtDNA loaded with the fusogens can be mation and indefinite replication of mtDNA. As a simple remedy for the malfunction of a tissue, the idea of transferred into human organs through a branch of the portal vein. If the endothelial barrier is overcome, direct replacement by grafting has obvious appeal. However, there are many difficulties in grafting, such as suitable injection into a regional artery will be possible. Cytoplasts can also be infused into extracellular fluid in the donors and immunological reactions. Although wildtype mtDNA can be supplied from a donor, graft rejecpresence of hyaluronidase, if the cytoplasts are covered with positively charged residues to prevent phagocytosis. tion occurs when cytoplasts are implanted in allogeneic or xenogeneic recipients. Thus, normal cells are taken Introduction of wild-type mtDNA into mitochondria of mutant yeast cells with a particle gun has also been sucfrom a patient and proliferated in vitro before the cytoplast infusion, as in the case of skin grafting. However, cessful.
Introduction of cytoplasts into tissues seems similar to the replicative capacity of human somatic cells is limited to 50 divisions. This limited proliferation is caused by the tissue grafting, but differs fundamentally in cybrid for-
